Evidence map›Paper›PMID 30914431›Full record

ArticleCancer research2019

Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.

Galina V Shurin, Oleg Kruglov, Fei Ding, Yan Lin, Xingxing Hao, Anton A Keskinov, Zhaoyang You, Anna E Lokshin, William A LaFramboise, Louis D Falo and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Roles of Peripheral Nerves in Tumor Initiation and Progression.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Galina V Shurin *Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.ORCID 0000-0002-6570-7395
Oleg Kruglov *Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Fei DingDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Yan LinDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Xingxing HaoDepartment of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Anton A KeskinovDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Zhaoyang YouDepartment of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Anna E LokshinDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
William A LaFramboiseDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Louis D FaloDepartment of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Michael R ShurinDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.ORCID 0000-0002-6570-7395
Yuri L BunimovichDepartment of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. bunimovichyl@upmc.edu.
University of Pittsburgh Medical Center · USUPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Therapuetic Immune Targeting of EphA2 Expressed by Melanoma & Its Tumor-AssociateP50CA121973 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIRKWOOD, JOHN MUNN · 2008 to 2018
$22.9M
Regulation of Cardiolin Byosynthesis in Epithelial InjuryP01HL114453 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2014 to 2023
$21.3M
Validation of pancreatic cancer biomarkers in large prospective cohortsR01CA196286 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOKSHIN, ANNA E. · 2015 to 2017
$1.4M
Tumor Cell-derived HMGB1-initiated Activation of TregR21CA191522 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YOU, ZHAOYANG · 2015 to 2016
$359k
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA121973NCI NIH HHS R01 CA196286NCI NIH HHS R21 CA191522NHLBI NIH HHS P01 HL114453
6 · The paper itself

Abstract

The tumor microenvironment has been compared with a nonhealing wound involving a complex interaction between multiple cell types. Schwann cells, the key regulators of peripheral nerve repair, have recently been shown to directly affect nonneural wound healing. Their role in cancer progression, however, has been largely limited to neuropathic pain and perineural invasion. In this study, we showed that melanoma activated otherwise dormant functions of Schwann cells aimed at nerve regeneration and wound healing. Such reprogramming of Schwann cells into repair-like cells occurred during the destruction and displacement of neurons as the tumor expanded and via direct signaling from melanoma cells to Schwann cells, resulting in activation of the nerve injury response. Melanoma-activated Schwann cells significantly altered the microenvironment through their modulation of the immune system and the extracellular matrix in a way that promoted melanoma growth

Indexed as

AnimalsCell LineCell Line, TumorCell ProliferationExtracellular MatrixHumansMelanomaMiceMice, Inbred C57BLNerve RegenerationSchwann CellsSignal TransductionTumor MicroenvironmentWound Healing

Identifiers

PMID30914431
PMCPMC6522315
OpenAlexW2922685970

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.